CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,121 enrolled
Drug / intervention
Feedback +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05244122
NCT05244122N/ACompleted

Prevalence Effects in Visual Search: Theoretical and Practical Implications

Brigham and Women's Hospital·interventional·Posted Feb 17, 2022·Updated Oct 26, 2022

In Brief

A clinical study evaluating Feedback and Prevalence for Decision Making. Completed, enrolled 1,121 participants across 1 site.

Detailed Summary

Imagine that a dermatologist spends the morning seeing patients who have been referred for suspicion of skin cancer. Many of them do, in fact, have skin lesions that require treatment. For this set of patients, disease 'prevalence' would be high. Suppose that the next task is to spend the afternoon giving annual screening exams to members of the general population. Here disease prevalence will be low. Would the morning's work influence decisions about patients in the afternoon? It is known from other contexts that recent history can influence current decisions and that target prevalence has an impact on decisions. In this study, decisions were decisions about skin lesions from individuals with varying degrees of expertise, using an online, medical imaging labelling app (DiagnosUs). This allowed examination of the effects of feedback history and prevalence in a single study. Blocks of trials could be of low or high prevalence, with or without feedback. Over 300,000 individual judgements were collected. (taken from Wolfe, J. M. (2022). How one block of trials influences the next: Persistent effects of disease prevalence and feedback on decisions about images of skin lesions in a large online study. . Cognitive Research: Principles and Implications (CRPI), 7, 10. doi: https://doi.org/10.1186/s41235-022-00362-0

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDecision Making
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 17, 2022
Enrollment StartJun 22, 2021
Primary CompletionJun 27, 2021
TodayJul 2, 2026
Enrollment to primary: 5 daysPosted 4.4 years ago

Interventions

Feedbackbehavioral

presence or absence of trial by trial feedback

Prevalencebehavioral

In some blocks, skin cancer "target" images were present on 50% of trials (high prevalence). In other blocks, disease prevalence was 20%.